Cargando…

The effect of digoxin on renal function in patients with heart failure

INTRODUCTION: Digoxin is used in patients with chronic heart failure (CHF) who remain symptomatic despite optimal medical treatment. Impaired renal function is commonly associated with CHF. We investigated the relation between digoxin use and change in renal function over time in patients with CHF....

Descripción completa

Detalles Bibliográficos
Autores principales:	Shah, Parin, Pellicori, Pierpaolo, Hanning, Ian, Zhang, Jufen, Clark, Andrew L., Bhandari, Sunil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8549227/ https://www.ncbi.nlm.nih.gov/pubmed/34702219 http://dx.doi.org/10.1186/s12882-021-02562-0

Ejemplares similares

Warm water immersion in patients with chronic heart failure: a pilot study: Shah immerse: HF
por: Shah, Parin, et al.
Publicado: (2018)

Pharmacological and Non-pharmacological Treatment for Decompensated Heart Failure: What Is New?
por: Shah, Parin, et al.
Publicado: (2017)

Agreement and Classification Performance of Malnutrition Tools in Patients with Chronic Heart Failure
por: Sze, Shirley, et al.
Publicado: (2020)

Potential Effects of Digoxin on Renal Functions in Patients With Congestive Heart Failure
por: Alqahtani, Mesfer A, et al.
Publicado: (2023)

Prevalence, predictors, and prognostic implications of PR interval prolongation in patients with heart failure
por: Nikolaidou, Theodora, et al.
Publicado: (2017)

A comparison of non‐invasive methods of measuring body composition in patients with heart failure: a report from SICA‐HF
por: Shah, Parin, et al.
Publicado: (2021)

Cardiovascular Outcomes with Sacubitril-Valsartan in Heart Failure: Emerging Clinical Data
por: Cuthbert, Joseph J, et al.
Publicado: (2020)

Optimal Management of Heart Failure and Chronic Obstructive Pulmonary Disease: Clinical Challenges
por: Cuthbert, Joseph J, et al.
Publicado: (2022)

Interatrial shunt devices for heart failure with normal ejection fraction: a technology update
por: Cuthbert, Joseph J, et al.
Publicado: (2017)

The effects of short‐term omission of daily medication on the pathophysiology of heart failure
por: Dovancescu, Silviu, et al.
Publicado: (2017)

Digoxin Impact on Heart Failure Patients with Atrial Fibrillation
por: Gerakaris, Andreas, et al.
Publicado: (2022)

Effects of Digoxin in Heart Failure (HF) With Reduced Ejection Fraction (EF)
por: Parikh, Riya R, et al.
Publicado: (2022)

A Case of Digoxin Toxicity Due to Acute Renal Failure
por: Digiovanni-Kinsley, Stephanie, et al.
Publicado: (2021)

Efficacy and safety of digoxin in acute heart failure triggered by tachyarrhythmia
por: Shrestha, Samyut, et al.
Publicado: (2022)

Comparison of creatinine‐based equations for estimating renal function for digoxin dose adjustment in patients with atrial fibrillation and heart failure
por: Sakai, Masahiro, et al.
Publicado: (2023)

Observational cohort study of the safety of digoxin use in women with heart failure
por: Flory, James H, et al.
Publicado: (2012)

Editorial: Edema in heart failure with reduced ejection fraction
por: Gladysheva, Inna P., et al.
Publicado: (2023)

Effect of Chronic Digoxin Use on Mortality and Heart Failure Hospitalization in Pulmonary Arterial Hypertension
por: Chang, Kevin Y., et al.
Publicado: (2023)

A Meta-Analysis of the Therapeutic Effects of Glucagon-Like Peptide-1 Agonist in Heart Failure
por: Munaf, Mohammed, et al.
Publicado: (2012)

Assumption versus evidence: the case of digoxin in atrial fibrillation and heart failure
por: Bavendiek, Udo, et al.
Publicado: (2017)

Influence of serum transferrin concentration on diagnostic criteria for iron deficiency in chronic heart failure
por: Graham, Fraser J., et al.
Publicado: (2023)

Digoxin in management of heart failure in children: Should it be continued or relegated to the history books?
por: Jain, Shreepal, et al.
Publicado: (2009)

Digoxin is associated with worse outcomes in patients with heart failure with reduced ejection fraction
por: Zhou, Jingmin, et al.
Publicado: (2020)

Inferior vena cava diameter is associated with prognosis in patients with chronic heart failure independent of tricuspid regurgitation velocity
por: Iaconelli, Antonio, et al.
Publicado: (2023)

Digoxin use in contemporary heart failure with reduced ejection fraction: an analysis from the Swedish Heart Failure Registry
por: Kapelios, Chris J, et al.
Publicado: (2021)

The effect of digoxin on the binding of adriamycin to cat heart muscle.
por: Somberg, J., et al.
Publicado: (1977)

Defining Heart Failure Based on Imaging the Heart and Beyond
por: Graham, Fraser J, et al.
Publicado: (2023)

Dynamic risk stratification using Markov chain modelling in patients with chronic heart failure
por: Kazmi, Syed, et al.
Publicado: (2022)

Hypochloraemia in Patients with Heart Failure: Causes and Consequences
por: Cuthbert, Joseph J., et al.
Publicado: (2020)

New perspectives and future directions in the treatment of heart failure
por: Pellicori, Pierpaolo, et al.
Publicado: (2019)

Caring for people with heart failure and many other medical problems through and beyond the COVID‐19 pandemic: the advantages of universal access to home telemonitoring
por: Cleland, John G.F., et al.
Publicado: (2020)

Corrigendum to: Digoxin use in contemporary heart failure with reduced ejection fraction: An analysis from the Swedish Heart Failure Registry
Publicado: (2023)

Effect of frailty on treatment, hospitalisation and death in patients with chronic heart failure
por: Sze, S., et al.
Publicado: (2021)

Inappropriate use of digoxin in patients presenting with digoxin toxicity
por: Tatlisu, Mustafa Adem, et al.
Publicado: (2015)

Junctional Bradycardia as Early Sign of Digoxin Toxicity in a Premature Infant with Congestive Heart Failure due to a Left to Right Shunt
por: Dasgupta, Soham, et al.
Publicado: (2015)

Intermittent low-dose digoxin may be effective and safe in patients with chronic heart failure undergoing maintenance hemodialysis
por: LI, XIAOZHAO, et al.
Publicado: (2014)

Intravenous iron for heart failure with evidence of iron deficiency: a meta-analysis of randomised trials
por: Graham, Fraser J., et al.
Publicado: (2021)

Comparison Between Ivabradine and Low-Dose Digoxin in the Therapy of Diastolic Heart Failure with Preserved Left Ventricular Systolic Function
por: Cocco, Giuseppe, et al.
Publicado: (2013)

Association of digoxin with mortality and rehospitalization in heart failure patients treated with beta-blockers: Results from the Persian Heart Failure Patient Registry
por: Yazdi, Maryam, et al.
Publicado: (2022)

Glomerular filtration rate estimation using the Cockcroft-Gault and Modification of Diet in Renal Disease formulas for digoxin dose adjustment in patients with heart failure
por: Vazquez-Hernandez, Marta, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_ik1gm7j4papg2f3ukijr5b9pgg